Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome
This study has been terminated.
(Neurogen acquired by Ligand Pharmaceuticals - no further support for the study. No safety concerns identified.)
Sponsor:
Neurogen Corporation
Information provided by:
Neurogen Corporation
ClinicalTrials.gov Identifier:
NCT00834327
First received: January 30, 2009
Last updated: October 12, 2009
Last verified: October 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | December 2009 |
| Estimated Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |